Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells

The activity of type IV collagenase, which enables tumor cells to degrade collagen type IV found in the subendothelial basement membrane, has been correlated with the metastatic potential in several tumor types, including the rat 13762NF mammary adenocarcinoma cell line and its clones. In this study...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 1989-04, Vol.49 (7), p.1698-1706
Hauptverfasser: NAKAJIMA, M, LOTAN, D, BAIG, M. M, CARRALERO, R. M, WOOD, W. R, HENDRIX, M. J. C, LOTAN, R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1706
container_issue 7
container_start_page 1698
container_title Cancer research (Chicago, Ill.)
container_volume 49
creator NAKAJIMA, M
LOTAN, D
BAIG, M. M
CARRALERO, R. M
WOOD, W. R
HENDRIX, M. J. C
LOTAN, R
description The activity of type IV collagenase, which enables tumor cells to degrade collagen type IV found in the subendothelial basement membrane, has been correlated with the metastatic potential in several tumor types, including the rat 13762NF mammary adenocarcinoma cell line and its clones. In this study, we examined whether all-trans-retinoic acid (all-trans-RA) and other retinoids, which exhibit antitumor activity in vitro and in vivo, affect the collagenolytic activity of metastatic rat 13762NF mammary adenocarcinoma cells. Cells of the highly metastatic lung-colonizing clone MTF7.T35.3, derived from the 13762NF cell line, were treated for 3 days with 0.1, 1, or 10 microM all-trans-RA, harvested, and seeded on [3H]proline-labeled extracellular matrix deposited by cultured rat lung endothelial cells or on a film of purified [3H]proline-labeled type IV collagen. The amount of radioactivity released into the medium during the subsequent 24 to 72 h was measured, and it was found that all-trans-RA treatment inhibited degradation of extracellular matrix and type IV collagen by 50 to 60%. This effect was observed whether the cells had been treated with all-trans-RA in serum-free medium or in medium supplemented with heat-inactivated or acid-treated fetal bovine serum. The growth of the cells was not inhibited under these conditions, except after treatment with 10 microM all-trans-RA in serum-free medium. The reduction in collagenolytic activity was observed in viable cells as well as in conditioned medium. A 24-h exposure of cells to all-trans-RA was sufficient to cause a 30% decrease in the collagenolytic activity, and this inhibitory effect was reversible. The direct addition of all-trans-RA to conditioned medium had no effect on secreted collagenase activity. The apparent molecular weights of the collagenolytic enzymes were determined by electrophoresis of cell extracts and concentrated conditioned medium in type IV collagen-embedded polyacrylamide gels followed by renaturation and activation of the enzymes within the gels. Two major type IV collagenolytic metalloproteinases exhibiting molecular weights of 64,000 and 88,000, respectively, were detected by this method. These two enzymes were also found to have specificity for gelatin. The Mr 64,000 enzyme could be extracted from viable cells (presumably from the cell membrane) by 2% 1-butanol. Treatment with all-trans-RA decreased the level of these enzymes in the cellular, cell membrane, and conditioned medium c
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78874731</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78874731</sourcerecordid><originalsourceid>FETCH-LOGICAL-h268t-263728fb28c3782d95e7663c0cff6e3b2f66736bad980e9c23edb1a698eac1383</originalsourceid><addsrcrecordid>eNo9UM1KxDAQLqKs6-ojCDmIt0KbtEn2KIs_Cwte1OsySae7kSZZm1Too_i2plg8DcP3O3OWLcuayVxUVX2eLYuikHldCXqZXYXwmda6LOpFtqCJRBldZj9bdzTKROMdUSPpMRrnjSagTUN8S-J4QrL9INp3HRzQ-W4MJhBwDTHuG8Kki8feD4djEmvvQjRxiNgQBQEtukgsWtWDw8nfYoQQIaaEHhIE1kI_EmiSs4Zep3ALRGPXhevsooUu4M08V9n70-Pb5iXfvT5vNw-7_Ei5jDnlTFDZKio1E5I26xoF50wXum05MkVbzgXjCpq1LHCtKcNGlcDXEkGXTLJVdv_ne-r914Ah7q0JU4NU2Q9hL6QUlWBlIt7OxEFZbPan3kzl9_MvE3434xA0dG26WZvwTxNUVLKU7BcDJoH6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78874731</pqid></control><display><type>article</type><title>Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>NAKAJIMA, M ; LOTAN, D ; BAIG, M. M ; CARRALERO, R. M ; WOOD, W. R ; HENDRIX, M. J. C ; LOTAN, R</creator><creatorcontrib>NAKAJIMA, M ; LOTAN, D ; BAIG, M. M ; CARRALERO, R. M ; WOOD, W. R ; HENDRIX, M. J. C ; LOTAN, R</creatorcontrib><description>The activity of type IV collagenase, which enables tumor cells to degrade collagen type IV found in the subendothelial basement membrane, has been correlated with the metastatic potential in several tumor types, including the rat 13762NF mammary adenocarcinoma cell line and its clones. In this study, we examined whether all-trans-retinoic acid (all-trans-RA) and other retinoids, which exhibit antitumor activity in vitro and in vivo, affect the collagenolytic activity of metastatic rat 13762NF mammary adenocarcinoma cells. Cells of the highly metastatic lung-colonizing clone MTF7.T35.3, derived from the 13762NF cell line, were treated for 3 days with 0.1, 1, or 10 microM all-trans-RA, harvested, and seeded on [3H]proline-labeled extracellular matrix deposited by cultured rat lung endothelial cells or on a film of purified [3H]proline-labeled type IV collagen. The amount of radioactivity released into the medium during the subsequent 24 to 72 h was measured, and it was found that all-trans-RA treatment inhibited degradation of extracellular matrix and type IV collagen by 50 to 60%. This effect was observed whether the cells had been treated with all-trans-RA in serum-free medium or in medium supplemented with heat-inactivated or acid-treated fetal bovine serum. The growth of the cells was not inhibited under these conditions, except after treatment with 10 microM all-trans-RA in serum-free medium. The reduction in collagenolytic activity was observed in viable cells as well as in conditioned medium. A 24-h exposure of cells to all-trans-RA was sufficient to cause a 30% decrease in the collagenolytic activity, and this inhibitory effect was reversible. The direct addition of all-trans-RA to conditioned medium had no effect on secreted collagenase activity. The apparent molecular weights of the collagenolytic enzymes were determined by electrophoresis of cell extracts and concentrated conditioned medium in type IV collagen-embedded polyacrylamide gels followed by renaturation and activation of the enzymes within the gels. Two major type IV collagenolytic metalloproteinases exhibiting molecular weights of 64,000 and 88,000, respectively, were detected by this method. These two enzymes were also found to have specificity for gelatin. The Mr 64,000 enzyme could be extracted from viable cells (presumably from the cell membrane) by 2% 1-butanol. Treatment with all-trans-RA decreased the level of these enzymes in the cellular, cell membrane, and conditioned medium compartments.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 2538232</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adenocarcinoma - metabolism ; Animals ; Antineoplastic agents ; Basement Membrane - pathology ; Biological and medical sciences ; Collagen - metabolism ; Extracellular Matrix - metabolism ; General aspects ; Mammary Neoplasms, Experimental - metabolism ; Medical sciences ; Metalloendopeptidases - analysis ; Microbial Collagenase - analysis ; Molecular Weight ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Pharmacology. Drug treatments ; Rats ; Rats, Inbred F344 ; Tretinoin - pharmacology</subject><ispartof>Cancer research (Chicago, Ill.), 1989-04, Vol.49 (7), p.1698-1706</ispartof><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7274818$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2538232$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NAKAJIMA, M</creatorcontrib><creatorcontrib>LOTAN, D</creatorcontrib><creatorcontrib>BAIG, M. M</creatorcontrib><creatorcontrib>CARRALERO, R. M</creatorcontrib><creatorcontrib>WOOD, W. R</creatorcontrib><creatorcontrib>HENDRIX, M. J. C</creatorcontrib><creatorcontrib>LOTAN, R</creatorcontrib><title>Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>The activity of type IV collagenase, which enables tumor cells to degrade collagen type IV found in the subendothelial basement membrane, has been correlated with the metastatic potential in several tumor types, including the rat 13762NF mammary adenocarcinoma cell line and its clones. In this study, we examined whether all-trans-retinoic acid (all-trans-RA) and other retinoids, which exhibit antitumor activity in vitro and in vivo, affect the collagenolytic activity of metastatic rat 13762NF mammary adenocarcinoma cells. Cells of the highly metastatic lung-colonizing clone MTF7.T35.3, derived from the 13762NF cell line, were treated for 3 days with 0.1, 1, or 10 microM all-trans-RA, harvested, and seeded on [3H]proline-labeled extracellular matrix deposited by cultured rat lung endothelial cells or on a film of purified [3H]proline-labeled type IV collagen. The amount of radioactivity released into the medium during the subsequent 24 to 72 h was measured, and it was found that all-trans-RA treatment inhibited degradation of extracellular matrix and type IV collagen by 50 to 60%. This effect was observed whether the cells had been treated with all-trans-RA in serum-free medium or in medium supplemented with heat-inactivated or acid-treated fetal bovine serum. The growth of the cells was not inhibited under these conditions, except after treatment with 10 microM all-trans-RA in serum-free medium. The reduction in collagenolytic activity was observed in viable cells as well as in conditioned medium. A 24-h exposure of cells to all-trans-RA was sufficient to cause a 30% decrease in the collagenolytic activity, and this inhibitory effect was reversible. The direct addition of all-trans-RA to conditioned medium had no effect on secreted collagenase activity. The apparent molecular weights of the collagenolytic enzymes were determined by electrophoresis of cell extracts and concentrated conditioned medium in type IV collagen-embedded polyacrylamide gels followed by renaturation and activation of the enzymes within the gels. Two major type IV collagenolytic metalloproteinases exhibiting molecular weights of 64,000 and 88,000, respectively, were detected by this method. These two enzymes were also found to have specificity for gelatin. The Mr 64,000 enzyme could be extracted from viable cells (presumably from the cell membrane) by 2% 1-butanol. Treatment with all-trans-RA decreased the level of these enzymes in the cellular, cell membrane, and conditioned medium compartments.</description><subject>Adenocarcinoma - metabolism</subject><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Basement Membrane - pathology</subject><subject>Biological and medical sciences</subject><subject>Collagen - metabolism</subject><subject>Extracellular Matrix - metabolism</subject><subject>General aspects</subject><subject>Mammary Neoplasms, Experimental - metabolism</subject><subject>Medical sciences</subject><subject>Metalloendopeptidases - analysis</subject><subject>Microbial Collagenase - analysis</subject><subject>Molecular Weight</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Metastasis</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Tretinoin - pharmacology</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UM1KxDAQLqKs6-ojCDmIt0KbtEn2KIs_Cwte1OsySae7kSZZm1Too_i2plg8DcP3O3OWLcuayVxUVX2eLYuikHldCXqZXYXwmda6LOpFtqCJRBldZj9bdzTKROMdUSPpMRrnjSagTUN8S-J4QrL9INp3HRzQ-W4MJhBwDTHuG8Kki8feD4djEmvvQjRxiNgQBQEtukgsWtWDw8nfYoQQIaaEHhIE1kI_EmiSs4Zep3ALRGPXhevsooUu4M08V9n70-Pb5iXfvT5vNw-7_Ei5jDnlTFDZKio1E5I26xoF50wXum05MkVbzgXjCpq1LHCtKcNGlcDXEkGXTLJVdv_ne-r914Ah7q0JU4NU2Q9hL6QUlWBlIt7OxEFZbPan3kzl9_MvE3434xA0dG26WZvwTxNUVLKU7BcDJoH6</recordid><startdate>19890401</startdate><enddate>19890401</enddate><creator>NAKAJIMA, M</creator><creator>LOTAN, D</creator><creator>BAIG, M. M</creator><creator>CARRALERO, R. M</creator><creator>WOOD, W. R</creator><creator>HENDRIX, M. J. C</creator><creator>LOTAN, R</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19890401</creationdate><title>Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells</title><author>NAKAJIMA, M ; LOTAN, D ; BAIG, M. M ; CARRALERO, R. M ; WOOD, W. R ; HENDRIX, M. J. C ; LOTAN, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h268t-263728fb28c3782d95e7663c0cff6e3b2f66736bad980e9c23edb1a698eac1383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adenocarcinoma - metabolism</topic><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Basement Membrane - pathology</topic><topic>Biological and medical sciences</topic><topic>Collagen - metabolism</topic><topic>Extracellular Matrix - metabolism</topic><topic>General aspects</topic><topic>Mammary Neoplasms, Experimental - metabolism</topic><topic>Medical sciences</topic><topic>Metalloendopeptidases - analysis</topic><topic>Microbial Collagenase - analysis</topic><topic>Molecular Weight</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Metastasis</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Tretinoin - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NAKAJIMA, M</creatorcontrib><creatorcontrib>LOTAN, D</creatorcontrib><creatorcontrib>BAIG, M. M</creatorcontrib><creatorcontrib>CARRALERO, R. M</creatorcontrib><creatorcontrib>WOOD, W. R</creatorcontrib><creatorcontrib>HENDRIX, M. J. C</creatorcontrib><creatorcontrib>LOTAN, R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NAKAJIMA, M</au><au>LOTAN, D</au><au>BAIG, M. M</au><au>CARRALERO, R. M</au><au>WOOD, W. R</au><au>HENDRIX, M. J. C</au><au>LOTAN, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1989-04-01</date><risdate>1989</risdate><volume>49</volume><issue>7</issue><spage>1698</spage><epage>1706</epage><pages>1698-1706</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>The activity of type IV collagenase, which enables tumor cells to degrade collagen type IV found in the subendothelial basement membrane, has been correlated with the metastatic potential in several tumor types, including the rat 13762NF mammary adenocarcinoma cell line and its clones. In this study, we examined whether all-trans-retinoic acid (all-trans-RA) and other retinoids, which exhibit antitumor activity in vitro and in vivo, affect the collagenolytic activity of metastatic rat 13762NF mammary adenocarcinoma cells. Cells of the highly metastatic lung-colonizing clone MTF7.T35.3, derived from the 13762NF cell line, were treated for 3 days with 0.1, 1, or 10 microM all-trans-RA, harvested, and seeded on [3H]proline-labeled extracellular matrix deposited by cultured rat lung endothelial cells or on a film of purified [3H]proline-labeled type IV collagen. The amount of radioactivity released into the medium during the subsequent 24 to 72 h was measured, and it was found that all-trans-RA treatment inhibited degradation of extracellular matrix and type IV collagen by 50 to 60%. This effect was observed whether the cells had been treated with all-trans-RA in serum-free medium or in medium supplemented with heat-inactivated or acid-treated fetal bovine serum. The growth of the cells was not inhibited under these conditions, except after treatment with 10 microM all-trans-RA in serum-free medium. The reduction in collagenolytic activity was observed in viable cells as well as in conditioned medium. A 24-h exposure of cells to all-trans-RA was sufficient to cause a 30% decrease in the collagenolytic activity, and this inhibitory effect was reversible. The direct addition of all-trans-RA to conditioned medium had no effect on secreted collagenase activity. The apparent molecular weights of the collagenolytic enzymes were determined by electrophoresis of cell extracts and concentrated conditioned medium in type IV collagen-embedded polyacrylamide gels followed by renaturation and activation of the enzymes within the gels. Two major type IV collagenolytic metalloproteinases exhibiting molecular weights of 64,000 and 88,000, respectively, were detected by this method. These two enzymes were also found to have specificity for gelatin. The Mr 64,000 enzyme could be extracted from viable cells (presumably from the cell membrane) by 2% 1-butanol. Treatment with all-trans-RA decreased the level of these enzymes in the cellular, cell membrane, and conditioned medium compartments.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>2538232</pmid><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1989-04, Vol.49 (7), p.1698-1706
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_78874731
source MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals
subjects Adenocarcinoma - metabolism
Animals
Antineoplastic agents
Basement Membrane - pathology
Biological and medical sciences
Collagen - metabolism
Extracellular Matrix - metabolism
General aspects
Mammary Neoplasms, Experimental - metabolism
Medical sciences
Metalloendopeptidases - analysis
Microbial Collagenase - analysis
Molecular Weight
Neoplasm Invasiveness
Neoplasm Metastasis
Pharmacology. Drug treatments
Rats
Rats, Inbred F344
Tretinoin - pharmacology
title Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A47%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20by%20retinoic%20acid%20of%20type%20IV%20collagenolysis%20and%20invasion%20through%20reconstituted%20basement%20membrane%20by%20metastatic%20rat%20mammary%20adenocarcinoma%20cells&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=NAKAJIMA,%20M&rft.date=1989-04-01&rft.volume=49&rft.issue=7&rft.spage=1698&rft.epage=1706&rft.pages=1698-1706&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E78874731%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78874731&rft_id=info:pmid/2538232&rfr_iscdi=true